CC Bio
2 known investors
Find your way into CC Bio
CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision. The company uses its proprietary Zeus platform to discover and optimize first-in-class treatments for patients seeking alternatives to antibiotics.
Founders & leadership
DM
Dr Matthew CummingsCo-Founder, CC Bio
DD
Dr David CorcoranCo-Founder, CC Bio
Investors · 2
In the news
Frequently asked questions
- What does CC Bio do?
- CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision. The company uses its proprietary Zeus platform to discover and optimize first-in-class treatments for patients seeking alternatives to antibiotics.
- Who founded CC Bio?
- CC Bio was founded by Dr Matthew Cummings, Dr David Corcoran.
- Who are CC Bio's investors?
- CC Bio's investors include Deep Science Ventures, CMS Ventures.